基本信息
浏览量:464
职业迁徙
个人简介
Scientific progress is generating myriad opportunities for ground-breaking medicines and therapies, and it is my belief that industry has to pioneer new approaches to drug discovery and development to bring these therapies to patients. This ambition to challenge the status quo sits at the very heart of my approach to both science and leadership.
Whether it’s engineering new models of collaboration with academia (e.g. GSK’s Immunology Network), simplifying processes and ways of working (to reduce PII cycle times by c.50% at GSK), or sponsoring disruptive technologies and business models (e.g. in the Flagship Pioneering biotech Kintai Therapeutics that invented Precision Enteric Medicines), I aim to bring creative, energising and empowering leadership to all that I do.
In my own career, I’ve been at my best when I’ve had the freedom to think and explore, be stimulated by others’ points of view and able to challenge received wisdom. These are the principles that guide my approach to leadership and that help me to unite teams around ideas and drive outstanding performance. I also believe these principles build a collaborative and inspiring culture that is able to realize the many opportunities ahead of us.
Whether it’s engineering new models of collaboration with academia (e.g. GSK’s Immunology Network), simplifying processes and ways of working (to reduce PII cycle times by c.50% at GSK), or sponsoring disruptive technologies and business models (e.g. in the Flagship Pioneering biotech Kintai Therapeutics that invented Precision Enteric Medicines), I aim to bring creative, energising and empowering leadership to all that I do.
In my own career, I’ve been at my best when I’ve had the freedom to think and explore, be stimulated by others’ points of view and able to challenge received wisdom. These are the principles that guide my approach to leadership and that help me to unite teams around ideas and drive outstanding performance. I also believe these principles build a collaborative and inspiring culture that is able to realize the many opportunities ahead of us.
研究兴趣
论文共 1256 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Francesca Barone,Alexander Ling,Isaac H. Solomon, Ana Montalvo Landivar,Hiroshi Nakashima,Andrea Manzanera, Maria Lucia Silva Polanco,Andres Santos, Nafisa Masud,Patrick Wen, Keith Leigon,David Reardon,
MOLECULAR THERAPYno. 5 (2023): 2-3
引用0浏览0引用
0
0
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
引用0浏览0引用
0
0
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
引用0浏览0引用
0
0
Francesca Barone,Paul P Tak,Mark Bloomston, Elizabeth Webber, Jessica Dwyer, W Garrett Nichols, David Huitzil, Vanessa Rosas-Camargo, Marcos Ramirez-Marquez, Alejandra Murillo-Cordova, Randy Swan
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
引用0浏览0引用
0
0
Charu Aggarwal,Daniel Sterman,Fabien Maldonado,Christine M. Bestvina,Janani S. Reisenauer,Howard Li,Sonam Puri, Omar Ibrahim, Randy Swan, Audra Caine, Lenika Lopez,Andrea G. Manzanera,
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS9162-TPS9162
FRONTIERS IN MEDICINE (2023): 1140352
引用0浏览0WOS引用
0
0
Biomedicinesno. 2 (2022): 324-324
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn